189 related articles for article (PubMed ID: 27500301)
1. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
[TBL] [Abstract][Full Text] [Related]
2. Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.
Alonso-Coello P; Ebrahim S; Guyatt GH; Tikkinen KA; Eckman MH; Neumann I; McDonald SD; Akl EA; Bates SM
BMC Pregnancy Childbirth; 2012 May; 12():40. PubMed ID: 22646475
[TBL] [Abstract][Full Text] [Related]
3. Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.
Eckman MH; Alonso-Coello P; Guyatt GH; Ebrahim S; Tikkinen KA; Lopes LC; Neumann I; McDonald SD; Zhang Y; Zhou Q; Akl EA; Jacobsen AF; Santamaría A; Annichino-Bizzacchi JM; Bitar W; Sandset PM; Bates SM
Thromb Res; 2015 Aug; 136(2):341-7. PubMed ID: 26033397
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
[TBL] [Abstract][Full Text] [Related]
7. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
[TBL] [Abstract][Full Text] [Related]
8. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
Rath W
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
[TBL] [Abstract][Full Text] [Related]
9. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review.
León-García M; Humphries B; Maraboto A; Rabassa M; Boehmer KR; Perestelo-Perez L; Xie F; Pelayo I; Eckman M; Bates S; Selva A; Alonso-Coello P
BMC Pregnancy Childbirth; 2022 Oct; 22(1):747. PubMed ID: 36199014
[TBL] [Abstract][Full Text] [Related]
10. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.
Skeith L; Carrier M; Robinson SE; Alimam S; Rodger MA
Blood; 2017 Feb; 129(8):934-939. PubMed ID: 28049641
[TBL] [Abstract][Full Text] [Related]
12. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
[TBL] [Abstract][Full Text] [Related]
13. [Thromboprophylaxis in pregnant women should be individually tailored].
Spaanderman MA
Ned Tijdschr Geneeskd; 2011; 155(18):A3568. PubMed ID: 21557830
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].
Rath W; Tsikouras P; von Tempelhoff GF
Z Geburtshilfe Neonatol; 2016 Jun; 220(3):95-105. PubMed ID: 27315397
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
[TBL] [Abstract][Full Text] [Related]
16. A Multicentre Study of Thromboprophylaxis in Pregnancy.
Crowley MP; Noone C; Higgins JR; O'Shea S
Ir Med J; 2017 May; 110(5):567. PubMed ID: 28737308
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prophylaxis of the obese postpartum patient: A cross-sectional study.
Gilmartin CE; Cutts BA; Ismail H
Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):376-381. PubMed ID: 31514236
[TBL] [Abstract][Full Text] [Related]
18. Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women.
Ismail SK; Norris L; O'Shea S; Higgins JR
Thromb Res; 2014 Aug; 134(2):234-9. PubMed ID: 24984985
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis in adult and paediatric burn patients: A survey of practice in the United Kingdom.
Vermaak PV; D'Asta F; Provins J; Farr M; Wilson YT
Burns; 2019 Sep; 45(6):1379-1385. PubMed ID: 31079961
[TBL] [Abstract][Full Text] [Related]
20. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
